Search

Search Constraints

You searched for: Author/Creator Salvatore, Lisa

Search Results

11. Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association. Issue 6 (1st December 2020)

12. Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association. Issue 6 (1st December 2020)

13. Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial. (March 2019)

14. Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer. (November 2017)

15. Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer. (September 2022)

16. Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer. Issue 1 (28th May 2014)

17. Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin‐based chemotherapy in patients with metastatic colorectal cancer. Issue 22 (14th July 2017)

18. Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial. Issue 14 (10th May 2022)

19. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 7 (July 2022)